Scientific Publication

A landmark UCSF study has mapped the molecular machinery of autism, revealing convergent pathways. This isn't just a breakthrough for ASD; it's a new model for drug discovery.

A landmark study reveals that children of centenarians inherit a powerful biological advantage, rewriting our understanding of aging, health, and longevity.

With zero recurrences in a pivotal trial, a novel immunotherapy combination is rewriting the rules for early-stage colon cancer, targeting tumors once thought untouchable.

A new report reveals a startling fatigue crisis in college sports, suggesting a generation armed with smart rings is overlooking the most powerful performance enhancer of all: the body’s internal clock.

A new study reveals most AIs are built on a flawed philosophy of 'proving' truth, leading to misinformation. Can a new approach teach them to doubt?

The American Botanical Council is making a high-stakes play to rebrand coca. Can a strategic campaign of science and media finally sever the link to cocaine?

A new study uncovers the neurophysiology of driving joy, finding the ultimate thrill isn't on the speedometer but in a state of 'flow'.

New research analyzing 4,000 deals finds the most common sales strategy is also the least effective. The data signals a seismic shift from gut-feel to science.

A new study shows AliveCor's KardiaMobile 6L device nearly doubles arrhythmia detection, signaling a major shift from clinics to patient-led home care.

A landmark study validates Kandu's at-home IpsiHand, showing over half of chronic stroke patients can regain meaningful hand function years after injury.

A San Diego biotech is advancing a device to clean the blood of disease-fueling particles. With early promise in cancer and a new path in Long COVID, can it navigate the financial realities of innovation?

A landmark study proves the link between environmental action and financial performance is not direct, but flows through a powerful new channel: consumer sales.

It's not just about investing in AI. A new study reveals companies detailing specific deployments in filings see 8% more revenue growth. Here's why.

Consumer wearables promise health insights but often fall short on accuracy. A new study shows a surprising fix: using synchronized sensors on both hands.

RyboDyn's RyboCypher platform is uncovering a 'dark proteome' full of tumor-specific targets, promising a new era beyond today's crowded drug pipeline.

OTraces' new AI analyzes biological 'noise' to forecast Type 1 Diabetes with over 92% accuracy, promising a new era of early intervention and care.

An innovative AI technology, once used to analyze NBA athletes, is now being used in a landmark Canadian study to prove how automated systems can save careers and lives.

A Utah biotech's new blood test can identify the exact brain cells dying in diseases like Alzheimer's, a major leap beyond today's diagnostics.

A biotech firm has uncovered a self-perpetuating cycle that drives Alzheimer's from within the cell's mitochondria, and they've developed a drug to break it.

A landmark study on equicenta® CTM shows it nearly triples a horse's odds of returning to performance, offering a ready-to-use solution that challenges the status quo.